Inovio Pharmaceuticals, Inc. announced a public offering on November 11, 2025, to sell 13,158,000 shares of common stock at $1.90 each, aiming to raise approximately $26.5 million after expenses. The offering includes an option for underwriters to purchase 1,973,700 additional shares, which was fully exercised on the same date.